Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

38.54 USD +0.46 (+1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,255
Open 38.17
Bid (Size) 38.54 (2)
Ask (Size) 38.59 (3)
Prev. Close 38.08
Today's Range 37.51 - 39.39
52wk Range 23.55 - 40.00
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor... 
From Business Wire News Releases
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. 
From Business Wire News Releases

Performance

YTD
+27.53%
+27.53%
1 Month
+20.97%
+20.97%
3 Month
+15.81%
+15.81%
6 Month
+17.46%
+17.46%
1 Year
+35.18%
+35.18%

More News

Read More
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Sy
From Business Wire News Releases
ANI Pharmaceuticals Reports Second Quarter 2021 Results
From Business Wire News Releases
7 Overbought Stocks to Be Very Careful of Right Now
Tags PBCT CF AAWW
From InvestorPlace
Analysts Predict 24% Gains Ahead For PSCH
Tags ETFs
From ETF Channel
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
From Business Wire News Releases
Looking Into ANI Pharmaceuticals's Return On Capital Employed
Tags ANIP Benzinga Market News
From Benzinga
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
From Business Wire News Releases
ANI Pharma's Purified Cortrophin Gel Application Under FDA Review
Tags Benzinga Small Cap Biotech
From Benzinga
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.